Earnings results
Quarterly results as US companies announce them to the SEC (Form 8-K, Item 2.02), with figures from each company’s own filed statements. About half of companies file detailed figures the same day they announce; the rest show as pending until the quarterly statement arrives. No analyst estimates, no consensus: what was reported, compared with the same quarter a year earlier.
10,796 announcements in the last 12 months · page 95 of 108
| Announced | Company | Period | Revenue | Rev YoY | Net income | EPS | EPS YoY | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-01-20 | Forestar Group Inc. (FOR) | Q1 FY2026 | $273.0M | 9.0% | $15.4M | 0.30 | -6.3% | 8-K |
| 2026-01-20 | Interactive Brokers Group, Inc. (IBKR) | Q4 FY2025 | $667.0M | 19.5% | $1.20B | — | — | 8-K |
| 2026-01-20 | Interpace Biosciences, Inc. (IDXG) | Q4 FY2025 | $9.2M | -25.7% | $22.7M | 0.82 | 2046.1% | 8-K |
| 2026-01-20 | Keycorp (KEY) | Q4 FY2025 | $2.00B | 133.6% | $510.0M | 0.46 | — | 8-K |
| 2026-01-20 | 3M Co. (MMM) | Q4 FY2025 | $6.13B | 2.0% | $577.0M | 1.07 | -19.7% | 8-K |
| 2026-01-20 | Msc Income Fund, Inc. (MSIF) | Q4 FY2025 | — | — | $30.0M | 0.64 | 25.8% | 8-K |
| 2026-01-20 | Netflix Inc. (NFLX) | Q4 FY2025 | $12.05B | 17.6% | $2.42B | 0.56 | — | 8-K |
| 2026-01-20 | Orion Energy Systems, Inc. (OESX) | Q3 FY2026 | $21.1M | 7.7% | $160,000 | 0.04 | — | 8-K |
| 2026-01-20 | Occidental Petroleum Corp. (OXY) | Q4 FY2025 | $1.66B | 13.1% | $114.0M | 0.11 | — | 8-K |
| 2026-01-20 | Progress Software Corp. (PRGS) | Q4 FY2025 | $252.7M | 17.5% | $25.7M | 0.59 | 2242.6% | 8-K |
| 2026-01-20 | Rockwell Medical, Inc. (RMTI) | Q4 FY2025 | $18.3M | -25.6% | $-554,000 | -0.01 | — | 8-K |
| 2026-01-20 | United Airlines Holdings, Inc. (UAL) | Q4 FY2025 | $15.40B | 4.8% | $1.04B | 3.19 | 7.9% | 8-K |
| 2026-01-20 | US Bancorp \de\ (USB) | Q4 FY2025 | $7.34B | 5.1% | $2.04B | 1.32 | 23.4% | 8-K |
| 2026-01-16 | Mesabi Trust (MSB) | Q3 FY2026 | $3.6M | -95.5% | $2.8M | — | — | 8-K |
| 2026-01-16 | M&t Bank Corp. (MTB) | Q4 FY2025 | $2.48B | 3.8% | $759.0M | 4.94 | 21.1% | 8-K |
| 2026-01-16 | Pnc Financial Services Group, Inc. (PNC) | Q4 FY2025 | $6.07B | 9.1% | $2.03B | 5.17 | 27.2% | 8-K |
| 2026-01-16 | Pennantpark Investment Corp. (PNNT) | Q1 FY2026 | — | — | $9.0M | — | — | 8-K |
| 2026-01-16 | Qnity Electronics, Inc. (Q) | Q4 FY2025 | $1.19B | 8.1% | $137.0M | 0.65 | -36.1% | 8-K |
| 2026-01-16 | State Street Corp. (STT) | Q4 FY2025 | $3.66B | 7.4% | $747.0M | 2.62 | -0.7% | 8-K |
| 2026-01-16 | Wafd Inc. (WAFD) | Q1 FY2026 | $191.4M | 11.8% | $64.2M | 0.79 | 46.3% | 8-K |
| 2026-01-16 | Wilson Bank Holding Co. (WBHC) | Q4 FY2025 | $60.8M | 24.2% | $22.3M | 1.83 | 46.0% | 8-K |
| 2026-01-15 | BlackRock, Inc. (BLK) | Q4 FY2025 | $7.01B | — | $1.13B | 6.82 | -35.9% | 8-K |
| 2026-01-15 | Vaalco Energy Inc. (EGY) | Q4 FY2025 | $91.0M | -25.2% | $-58.6M | -0.56 | -600.6% | 8-K |
| 2026-01-15 | FingerMotion, Inc. (FNGR) | Q3 FY2026 | $5.8M | -32.1% | $-1.7M | -0.03 | — | 8-K |
| 2026-01-15 | Goldman Sachs Group Inc. (GS) | Q4 FY2025 | $13.45B | -3.0% | $4.62B | 14.76 | 17.9% | 8-K |
| 2026-01-15 | ICF International, Inc. (ICFI) | Q4 FY2025 | $443.7M | -10.6% | $17.3M | 0.94 | -27.6% | 8-K |
| 2026-01-15 | Insteel Industries Inc. (IIIN) | Q1 FY2026 | $159.9M | 23.3% | $7.6M | 0.39 | 550.0% | 8-K |
| 2026-01-15 | Hunt J B Transport Services Inc. (JBHT) | Q4 FY2025 | $3.10B | -1.6% | $181.1M | 1.90 | 24.0% | 8-K |
| 2026-01-15 | Morgan Stanley (MS) | Q4 FY2025 | $6.31B | -26.6% | $4.40B | 2.77 | 20.0% | 8-K |
| 2026-01-15 | Nabors Industries Ltd. (NBR) | Q4 FY2025 | $797.5M | 9.3% | $10.3M | 0.67 | — | 8-K |
| 2026-01-15 | Prudential Financial Inc. (PRU) | Q4 FY2025 | $15.69B | 25.3% | $905.0M | 2.58 | — | 8-K |
| 2026-01-15 | Quantum Corp. (QMCO) | Q3 FY2026 | $74.6M | 8.6% | $-27.8M | -2.03 | — | 8-K |
| 2026-01-14 | Bank of America Corp. (BAC) | Q4 FY2025 | $31.18B | 6.4% | $7.53B | 1.00 | 20.3% | 8-K |
| 2026-01-14 | Biogen Inc. (BIIB) | Q4 FY2025 | $2.28B | -7.1% | $-48.9M | -0.33 | -118.0% | 8-K |
| 2026-01-14 | Citigroup Inc. (C) | Q4 FY2025 | $19.87B | 2.1% | $2.47B | 1.36 | -8.1% | 8-K |
| 2026-01-14 | Compass Diversified Holdings (CODI) | Q4 FY2025 | $468.6M | -5.1% | $-71.2M | -0.95 | — | 8-K |
| 2026-01-14 | Diversified Healthcare Trust (DHC) | Q4 FY2025 | $379.6M | -0.0% | $-21.2M | -0.09 | — | 8-K |
| 2026-01-14 | Intuitive Surgical Inc. (ISRG) | Q4 FY2025 | $2.87B | 18.8% | $794.8M | 2.21 | 17.0% | 8-K |
| 2026-01-14reported in filing | Jewett Cameron Trading Co. Ltd. (JCTC) | Q1 FY2026 | $8.7M | -6.6% | $-3.9M | -1.12 | — | 8-K |
| 2026-01-14 | SemiLEDs Corp (LEDS) | Q1 FY2026 | $2.6M | 103.7% | $-742,000 | -0.09 | — | 8-K |
| 2026-01-14 | Loop Industries, Inc. (LOOP) | Q3 FY2026 | $86,000 | 65.4% | $-2.9M | — | — | 8-K |
| 2026-01-14 | R F Industries Ltd. (RFIL) | Q4 FY2025 | $22.7M | 22.9% | $173,000 | 0.02 | — | 8-K |
| 2026-01-14 | Wells Fargo & Company (WFC) | Q4 FY2025 | $21.29B | 4.5% | $5.36B | 1.70 | 12.3% | 8-K |
| 2026-01-13 | Audioeye Inc. (AEYE) | Q4 FY2025 | $10.5M | 7.9% | $-1.1M | -0.08 | — | 8-K |
| 2026-01-13 | Aircastle LTD (AYR) | Q3 FY2025 | $236.4M | 22.1% | $30.7M | — | — | 8-K |
| 2026-01-13 | Concrete Pumping Holdings, Inc. (BBCP) | Q4 FY2025 | $98.9M | -3.2% | $5.3M | 0.10 | -42.6% | 8-K |
| 2026-01-13 | Biofrontera Inc. (BFRI) | Q4 FY2025 | $17.1M | 36.2% | $5.6M | 0.48 | — | 8-K |
| 2026-01-13 | Bausch Health Companies Inc. (BHC) | Q4 FY2025 | $2.80B | 9.3% | $-112.0M | -0.30 | -217.6% | 8-K |
| 2026-01-13 | Coherus Oncology, Inc. (CHRS) | Q4 FY2025 | $12.7M | 64.9% | $-37.6M | -0.31 | — | 8-K |
| 2026-01-13 | Delta Air Lines, Inc. (DAL) | Q4 FY2025 | $16.00B | 2.9% | $1.22B | 1.86 | 43.3% | 8-K |
| 2026-01-13 | Illumina, Inc. (ILMN) | Q4 FY2025 | — | — | $334.0M | — | — | 8-K |
| 2026-01-13 | JPMorgan Chase & Co. (JPM) | Q4 FY2025 | $45.80B | 7.1% | $13.03B | 4.75 | -3.5% | 8-K |
| 2026-01-13 | Latch, Inc. (LTCH) | Q4 FY2025 | $17.9M | 6.9% | $-28.1M | -0.17 | — | 8-K |
| 2026-01-13 | Park Aerospace Corp. (PKE) | Q3 FY2026 | $17.3M | 20.3% | $3.0M | 0.15 | 87.5% | 8-K |
| 2026-01-13 | Red Cat Holdings, Inc. (RCAT) | Q4 FY2025 | $26.2M | 315.8% | $-19.7M | -0.16 | — | 8-K |
| 2026-01-13 | AVITA Medical, Inc. (RCEL) | Q4 FY2025 | $16.9M | -6.4% | $-11.6M | -0.38 | — | 8-K |
| 2026-01-13 | Royal Gold Inc. (RGLD) | Q4 FY2025 | $375.3M | 85.3% | $93.6M | 1.16 | -28.9% | 8-K |
| 2026-01-13 | Rci Hospitality Holdings, Inc. (RICK) | Q1 FY2026 | $70.8M | -0.9% | $-4.7M | -0.57 | -156.4% | 8-K |
| 2026-01-13 | Rocky Mountain Chocolate Factory, Inc. (RMCF) | Q3 FY2026 | $7.5M | -4.4% | $-155,000 | -0.02 | — | 8-K |
| 2026-01-13 | Solitron Devices Inc. (SODI) | Q3 FY2026 | $5.0M | 49.1% | $653,000 | — | — | 8-K |
| 2026-01-13 | Sono Tek Corp. (SOTK) | Q3 FY2026 | $5.0M | -3.6% | $339,959 | 0.02 | 0.0% | 8-K |
| 2026-01-12reported in filing | AI Financial Corp (AIFC) | Q4 FY2025 | $5.4M | 12.5% | $-381.5M | — | — | 8-K |
| 2026-01-12 | Alnylam Pharmaceuticals, Inc. (ALNY) | Q4 FY2025 | $1.10B | 84.9% | $111.5M | 0.82 | — | 8-K |
| 2026-01-12 | Allurion Technologies, Inc. (ALUR) | Q4 FY2025 | $3.6M | -35.4% | $-6.0M | -0.59 | — | 8-K |
| 2026-01-12 | Apyx Medical Corp (APYX) | Q4 FY2025 | $19.2M | 34.7% | $-1.3M | — | — | 8-K |
| 2026-01-12 | AtriCure, Inc. (ATRC) | Q4 FY2025 | $140.5M | 13.1% | $1.8M | 0.04 | — | 8-K |
| 2026-01-12 | Brookdale Senior Living Inc. (BKD) | Q4 FY2025 | $754.1M | -3.4% | $-40.0M | -0.17 | — | 8-K |
| 2026-01-12 | BillionToOne, Inc. (BLLN) | Q4 FY2025 | $96.1M | 113.1% | $6.0M | 0.15 | — | 8-K |
| 2026-01-12 | Bionano Genomics, Inc. (BNGO) | Q4 FY2025 | $8.0M | -2.6% | $-7.9M | -0.78 | — | 8-K |
| 2026-01-12 | Caris Life Sciences, Inc. (CAI) | Q4 FY2025 | $292.9M | 125.4% | $82.0M | 0.29 | — | 8-K |
| 2026-01-12 | Carlsmed, Inc. (CARL) | Q4 FY2025 | $15.2M | 61.2% | $-8.6M | -0.32 | — | 8-K |
| 2026-01-12 | Crown Castle Inc. (CCI) | Q4 FY2025 | $1.07B | -4.3% | $294.0M | 0.67 | — | 8-K |
| 2026-01-12 | Concentra Group Holdings Parent, Inc. (CON) | Q4 FY2025 | $539.1M | 15.9% | $34.7M | 0.27 | 59.9% | 8-K |
| 2026-01-12 | Crescent Energy Co (CRGY) | Q4 FY2025 | $865.0M | -1.2% | $-8.7M | — | — | 8-K |
| 2026-01-12 | CVRx, Inc. (CVRX) | Q4 FY2025 | $16.0M | 4.4% | $-11.9M | -0.46 | — | 8-K |
| 2026-01-12 | Delcath Systems, Inc. (DCTH) | Q4 FY2025 | $20.7M | 37.3% | $-1.9M | -0.05 | — | 8-K |
| 2026-01-12 | Quest Diagnostics Inc. (DGX) | Q4 FY2025 | $2.81B | 7.1% | $245.0M | 2.17 | 13.3% | 8-K |
| 2026-01-12 | Danaher Corp. (DHR) | Q4 FY2025 | $6.84B | 4.6% | $1.20B | 1.68 | 13.0% | 8-K |
| 2026-01-12 | Dexcom Inc. (DXCM) | Q4 FY2025 | $1.26B | 13.1% | $267.3M | 0.67 | 79.6% | 8-K |
| 2026-01-12 | Eaco Corp. (EACO) | Q1 FY2026 | $111.0M | 18.1% | $9.3M | 1.90 | 34.8% | 8-K |
| 2026-01-12 | Elutia Inc. (ELUT) | Q4 FY2025 | $3.3M | 16.2% | $70.8M | 1.50 | — | 8-K |
| 2026-01-12 | Eog Resources Inc. (EOG) | Q4 FY2025 | $5.64B | 0.9% | $701.0M | 1.30 | -42.2% | 8-K |
| 2026-01-12 | Diamondback Energy, Inc. (FANG) | Q4 FY2025 | $3.38B | -9.0% | $-1.46B | -5.10 | -238.5% | 8-K |
| 2026-01-12 | Foghorn Therapeutics Inc. (FHTX) | Q4 FY2025 | $9.2M | 223.8% | $-21.7M | -0.34 | — | 8-K |
| 2026-01-12 | Edap Tms SA (FOCL) | Announced; detailed figures pending the quarterly statement | 8-K | |||||
| 2026-01-12 | Fulcrum Therapeutics, Inc. (FULC) | Q4 FY2025 | — | — | $-20.3M | -0.31 | — | 8-K |
| 2026-01-12 | Guardant Health, Inc. (GH) | Q4 FY2025 | $281.3M | 39.4% | $-128.5M | -1.00 | — | 8-K |
| 2026-01-12 | Hyperfine, Inc. (HYPR) | Q4 FY2025 | $5.3M | 128.0% | $-5.9M | -0.06 | — | 8-K |
| 2026-01-12 | Inogen Inc (INGN) | Q4 FY2025 | $68.6M | 3.4% | $-7.1M | -0.26 | — | 8-K |
| 2026-01-12 | Iridex Corp. (IRIX) | Q4 FY2026 | $14.7M | — | $-184,000 | -0.01 | — | 8-K |
| 2026-01-12 | Orthopediatrics Corp. (KIDS) | Q4 FY2025 | $61.6M | 17.0% | $-10.1M | -0.43 | — | 8-K |
| 2026-01-12 | Moderna, Inc. (MRNA) | Q4 FY2025 | $678.0M | -29.8% | $-826.0M | -2.11 | — | 8-K |
| 2026-01-12 | Maxcyte, Inc. (MXCT) | Q4 FY2025 | $4.8M | -20.9% | $-9.6M | -0.09 | — | 8-K |
| 2026-01-12 | NOODLES & Co (NDLS) | Q4 FY2025 | $122.8M | 0.8% | $-6.8M | — | — | 8-K |
| 2026-01-12 | Neostellar Capital Corp. (NSLR) | Q4 FY2025 | — | — | $-20.1M | -0.67 | -35521.1% | 8-K |
| 2026-01-12 | Natera, Inc. (NTRA) | Q4 FY2025 | $665.5M | 39.8% | $47.3M | 0.34 | — | 8-K |
| 2026-01-12 | Regeneron Pharmaceuticals, Inc. (REGN) | Q4 FY2025 | $3.88B | 2.5% | $844.6M | 7.84 | -2.9% | 8-K |
| 2026-01-12 | RxSight, Inc. (RXST) | Q4 FY2025 | $32.6M | -18.9% | $-9.2M | -0.22 | — | 8-K |
| 2026-01-12 | Syndax Pharmaceuticals Inc (SNDX) | Q4 FY2025 | $68.7M | 794.9% | $-68.0M | -0.78 | — | 8-K |
| 2026-01-12 | ONE Group Hospitality, Inc. (STKS) | Q4 FY2025 | $207.0M | -6.7% | $-6.4M | -0.20 | -490.7% | 8-K |
Source: SEC EDGAR. Figures are as reported in each company’s filings and may be unaudited or restated; a company that announces results in more than one filing (for example a delivery report and an earnings release) appears once per filing. Most rows come from an earnings release (Form 8-K, Item 2.02). Some companies file no separate release, so their periodic report is the event and the row is marked “reported in filing”. Foreign private issuers appear only where their Form 6-K tags the financial data itself, which is a minority of them: many report half-yearly, so there is no quarter to show and they are left out rather than listed without figures. Informational only. Not investment advice.